Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

The blood-brain barrier border protects the brain by regulating the flow of molecules, peptides, and cells, but it also keeps out many therapeutics. Now, researchers have harnessed the power of a ...

REAL AD hints that blood markers can spot subtle cognitive decline. People who fluff a digital cognitive test have more ...

For years, scientists have been working toward blood tests for Alzheimer’s disease that could be used routinely in clinical practice. Now, they are on the cusp. At this year’s ADPD conference, held ...

Dr. Zorn received a B.S. degree in Chemistry from Lafayette College, Easton, PA, and M.S. and Ph.D. degrees in Neurotoxicology and Neuropharmacology, respectively, from the University of Texas ...

Member reports the following financial or other potential conflicts of interest: Prof. Duñabeitia is as a scientific consultant for Fundación Salud Infantil and CogniFit.

Scientists see several important uses for staging. For example, it can steer people more precisely to appropriate treatments.

Single and multi-dose studies of the small molecule TREM2 agonist VG-3927 clear early safety hurdle. Meanwhile, new findings ...

Evidence suggests that in Parkinson’s disease, a breakdown in lysosomal function allows lipids to build up within cells. Variants of the GBA1 gene, the strongest genetic risk factor for sporadic PD, ...